602 related articles for article (PubMed ID: 38248857)
21. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
22. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression.
Wang R; Li B; Lam SM; Shui G
J Genet Genomics; 2020 Feb; 47(2):69-83. PubMed ID: 32178981
[TBL] [Abstract][Full Text] [Related]
23. [Development of a widely-targeted metabolomics method based on gas chromatography-mass spectrometry].
Wang YT; Yang Y; Sun XL; Ji J
Se Pu; 2023 Jun; 41(6):520-526. PubMed ID: 37259877
[TBL] [Abstract][Full Text] [Related]
24. Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
Cala MP; Agulló-Ortuño MT; Prieto-García E; González-Riano C; Parrilla-Rubio L; Barbas C; Díaz-García CV; García A; Pernaut C; Adeva J; Riesco MC; Rupérez FJ; Lopez-Martin JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):348-357. PubMed ID: 29464940
[TBL] [Abstract][Full Text] [Related]
25. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
[TBL] [Abstract][Full Text] [Related]
26. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
[TBL] [Abstract][Full Text] [Related]
27. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry.
Savolainen OI; Sandberg AS; Ross AB
J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962
[TBL] [Abstract][Full Text] [Related]
28. Metabolomics Research in Periodontal Disease by Mass Spectrometry.
Tsuchida S; Nakayama T
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566216
[TBL] [Abstract][Full Text] [Related]
29. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS.
Neef SK; Winter S; Hofmann U; Mürdter TE; Schaeffeler E; Horn H; Buck A; Walch A; Hennenlotter J; Ott G; Fend F; Bedke J; Schwab M; Haag M
Anal Chim Acta; 2020 Oct; 1134():125-135. PubMed ID: 33059858
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.
Siwy J; Ahonen L; Magalhães P; Frantzi M; Rossing P
Methods Mol Biol; 2020; 2067():287-306. PubMed ID: 31701458
[TBL] [Abstract][Full Text] [Related]
31. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update.
Kale D; Fatangare A; Phapale P; Sickmann A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132115
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics of neurological disorders in India.
Gupta S; Sharma U
Anal Sci Adv; 2021 Dec; 2(11-12):594-610. PubMed ID: 38715858
[TBL] [Abstract][Full Text] [Related]
33. Lipidomics applications for disease biomarker discovery in mammal models.
Zhao YY; Cheng XL; Lin RC; Wei F
Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
[TBL] [Abstract][Full Text] [Related]
34. Recent developments in liquid-phase separation techniques for metabolomics.
Ramautar R; de Jong GJ
Bioanalysis; 2014 Apr; 6(7):1011-26. PubMed ID: 24806908
[TBL] [Abstract][Full Text] [Related]
35. Liquid Chromatography-Mass Spectrometry for Clinical Metabolomics: An Overview.
Furlani IL; da Cruz Nunes E; Canuto GAB; Macedo AN; Oliveira RV
Adv Exp Med Biol; 2021; 1336():179-213. PubMed ID: 34628633
[TBL] [Abstract][Full Text] [Related]
36. The role of metabolomics in neonatal and pediatric laboratory medicine.
Mussap M; Antonucci R; Noto A; Fanos V
Clin Chim Acta; 2013 Nov; 426():127-38. PubMed ID: 24035970
[TBL] [Abstract][Full Text] [Related]
37. Analytical strategies in lipidomics and applications in disease biomarker discovery.
Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
[TBL] [Abstract][Full Text] [Related]
38. A critical appraisal of the role of metabolomics in breast cancer research and diagnostics.
Gadwal A; Panigrahi P; Khokhar M; Sharma V; Setia P; Vishnoi JR; Elhence P; Purohit P
Clin Chim Acta; 2024 Jun; 561():119836. PubMed ID: 38944408
[TBL] [Abstract][Full Text] [Related]
39. Metabolome analysis for investigating host-gut microbiota interactions.
Chen MX; Wang SY; Kuo CH; Tsai IL
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.
Jeanneret F; Tonoli D; Rossier MF; Saugy M; Boccard J; Rudaz S
J Chromatogr A; 2016 Jan; 1430():97-112. PubMed ID: 26195035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
